000			01683 a2200481 4500
005			20250514031253.0
264		0	_c20020904
008			200209s 0 0 eng d
022			_a0041-1345
024	7		_a10.1016/s0041-1345(01)02671-9 _2doi
040			_aNLM _beng _cNLM
100	1		_aMorales, E
245	0	0	_aProphylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy. _h[electronic resource]
260			_bTransplantation proceedings _cFeb 2002
300			_a73-4 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Viral _xtherapeutic use
650	0	4	_aAntilymphocyte Serum _xtherapeutic use
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aCytomegalovirus _ximmunology
650	0	4	_aCytomegalovirus Infections _xprevention & control
650	0	4	_aFemale
650	0	4	_aGanciclovir _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aKidney Transplantation _ximmunology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aRetrospective Studies
700	1		_aAndrés, A
700	1		_aGonzález, E
700	1		_aHerrero, J C
700	1		_aMuñoz, M A
700	1		_aOrtiz, M
700	1		_aEspejo, B
700	1		_aLumbreras, C
700	1		_aMorales, J M
700	1		_aAguado, J M
773	0		_tTransplantation proceedings _gvol. 34 _gno. 1 _gp. 73-4
856	4	0	_uhttps://doi.org/10.1016/s0041-1345(01)02671-9 _zAvailable from publisher's website
999			_c11861701 _d11861701